Adient Medical is pioneering the development of an absorbable vascular filter designed to prevent pulmonary embolism (PE), a significant health risk that claims over 100,000 lives annually in the U.S. This innovative device is made from polydioxanone, a flexible absorbable polymer that has been FDA-approved for surgical applications for four decades. The filter is inserted via catheter and functions by capturing blood clots for a duration of approximately 12 weeks, after which it dissolves naturally into carbon dioxide and water, eliminating the need for costly retrieval procedures. This technology not only aims to save lives by preventing PE but also addresses the complications associated with traditional metal filters, such as device fracture and organ perforation.

The absorbable filter's design is based on the understanding that its lifespan exceeds the risk period for developing blood clots, which is typically around five weeks. Studies conducted in collaboration with the University of Texas MD Anderson Cancer Center have demonstrated the filter's effectiveness in capturing clots of various sizes and its ability to maintain structural integrity during the critical protection period. Clinical trials, including a First in Human study, have shown promising results, with no reported cases of symptomatic PE or complications such as filter migration or thrombosis. This advancement in medical technology represents a significant step forward in providing safer and more effective solutions for patients at risk of pulmonary embolism.

United States

Adient Medical is a medical devices company that specializes in absorbable devices that automatically vanish, eliminating the need for removal procedures.

Adient Medical

Company Details